| Buddhist Tzu Chi Medical Foundation | |
|
1000 S. Garfield Ave. Alhambra CA 91801-4709 | |
| (626) 281-3383 | |
| (626) 281-5303 |
| Full Name | Buddhist Tzu Chi Medical Foundation |
|---|---|
| Speciality | Clinic/Center |
| Location | 1000 S. Garfield Ave., Alhambra, California |
| Authorized Official Name and Position | Fen-lien Juang (CREDENTIALING) |
| Authorized Official Contact | 6264279598 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Buddhist Tzu Chi Medical Foundation 9620 Flair Dr El Monte CA 91731-3005 Ph: (626) 427-9598 | Buddhist Tzu Chi Medical Foundation 1000 S. Garfield Ave. Alhambra CA 91801-4709 Ph: (626) 281-3383 |
| NPI Number | 1639398704 |
|---|---|
| Provider Enumeration Date | 04/25/2007 |
| Last Update Date | 06/07/2023 |
| Medicare PECOS PAC ID | 0941551261 |
|---|---|
| Medicare Enrollment ID | O20180926001998 |
News Archive
Patients with atherosclerosis—the buildup of cholesterol and fat in arteries—are at a higher risk of osteoporosis. A new study published in the American Journal of Physiology—Endocrinology and Metabolism shows how the development of atherosclerosis encourages the loss of bone density.
Six Ontario Researchers have received funding of $500,000 OR $1 million to further cancer research over the next five years, Cancer Care Ontario's Research Program announced today.
A newly published study is the first to report an association between bisphenol-A (BPA), a common plasticizer used in a variety of consumer food and beverage containers, with autism spectrum disorder (ASD) in children.
An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.
New early data showed that an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields - called Tumor-Treating Fields (TTFields) - more than doubled the median overall survival rates in patients with recurrent glioblastoma multiforme (GBM), the most common and aggressive type of malignant brain tumor.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639398704 | NPI | - | NPPES |
| Provider Name | Flora H Johnson |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1285782276 PECOS PAC ID: 0547329989 Enrollment ID: I20081030000316 |
News Archive
Patients with atherosclerosis—the buildup of cholesterol and fat in arteries—are at a higher risk of osteoporosis. A new study published in the American Journal of Physiology—Endocrinology and Metabolism shows how the development of atherosclerosis encourages the loss of bone density.
Six Ontario Researchers have received funding of $500,000 OR $1 million to further cancer research over the next five years, Cancer Care Ontario's Research Program announced today.
A newly published study is the first to report an association between bisphenol-A (BPA), a common plasticizer used in a variety of consumer food and beverage containers, with autism spectrum disorder (ASD) in children.
An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.
New early data showed that an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields - called Tumor-Treating Fields (TTFields) - more than doubled the median overall survival rates in patients with recurrent glioblastoma multiforme (GBM), the most common and aggressive type of malignant brain tumor.
› Verified 6 days ago
| Provider Name | Stephen Denq |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1568533073 PECOS PAC ID: 1153506977 Enrollment ID: I20110421000032 |
News Archive
Patients with atherosclerosis—the buildup of cholesterol and fat in arteries—are at a higher risk of osteoporosis. A new study published in the American Journal of Physiology—Endocrinology and Metabolism shows how the development of atherosclerosis encourages the loss of bone density.
Six Ontario Researchers have received funding of $500,000 OR $1 million to further cancer research over the next five years, Cancer Care Ontario's Research Program announced today.
A newly published study is the first to report an association between bisphenol-A (BPA), a common plasticizer used in a variety of consumer food and beverage containers, with autism spectrum disorder (ASD) in children.
An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.
New early data showed that an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields - called Tumor-Treating Fields (TTFields) - more than doubled the median overall survival rates in patients with recurrent glioblastoma multiforme (GBM), the most common and aggressive type of malignant brain tumor.
› Verified 6 days ago
| Provider Name | Peter F Chen |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1033163357 PECOS PAC ID: 0941234306 Enrollment ID: I20150219001175 |
News Archive
Patients with atherosclerosis—the buildup of cholesterol and fat in arteries—are at a higher risk of osteoporosis. A new study published in the American Journal of Physiology—Endocrinology and Metabolism shows how the development of atherosclerosis encourages the loss of bone density.
Six Ontario Researchers have received funding of $500,000 OR $1 million to further cancer research over the next five years, Cancer Care Ontario's Research Program announced today.
A newly published study is the first to report an association between bisphenol-A (BPA), a common plasticizer used in a variety of consumer food and beverage containers, with autism spectrum disorder (ASD) in children.
An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.
New early data showed that an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields - called Tumor-Treating Fields (TTFields) - more than doubled the median overall survival rates in patients with recurrent glioblastoma multiforme (GBM), the most common and aggressive type of malignant brain tumor.
› Verified 6 days ago
News Archive
Patients with atherosclerosis—the buildup of cholesterol and fat in arteries—are at a higher risk of osteoporosis. A new study published in the American Journal of Physiology—Endocrinology and Metabolism shows how the development of atherosclerosis encourages the loss of bone density.
Six Ontario Researchers have received funding of $500,000 OR $1 million to further cancer research over the next five years, Cancer Care Ontario's Research Program announced today.
A newly published study is the first to report an association between bisphenol-A (BPA), a common plasticizer used in a variety of consumer food and beverage containers, with autism spectrum disorder (ASD) in children.
An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.
New early data showed that an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields - called Tumor-Treating Fields (TTFields) - more than doubled the median overall survival rates in patients with recurrent glioblastoma multiforme (GBM), the most common and aggressive type of malignant brain tumor.
› Verified 6 days ago
Ssg Apctc Alhambra Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1635 W Main St Ste 100, Alhambra, CA 91801 Phone: 626-248-1800 | |
Patient Care Medical Center Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 320 S Garfield Ave Ste 206, Alhambra, CA 91801 Phone: 626-607-9406 Fax: 626-458-2489 | |
Thelma V Buan Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 123 N Garfield Ave, Suite C, Alhambra, CA 91801 Phone: 626-308-3781 Fax: 626-308-2113 | |
Paul Hovsepian, M.d. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 103 N Garfield Ave, Suite F, Alhambra, CA 91801 Phone: 626-282-2100 Fax: 626-281-0969 | |
Thida Win Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 100 S Raymond Ave, Alhambra, CA 91801 Phone: 626-677-8218 | |
Apc-lsma Designated Shareholder Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 925 S Garfield Ave, Alhambra, CA 91801 Phone: 626-282-0282 | |
Ap-amh 2 Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1668 S Garfield Ave Fl 2, Alhambra, CA 91801 Phone: 626-282-0288 |